首页> 外国专利> Compsn. for treating peripheral circulatory disorders - contains prostaglandin=E-1 or its deriv. and is given non-intra:arterially

Compsn. for treating peripheral circulatory disorders - contains prostaglandin=E-1 or its deriv. and is given non-intra:arterially

机译:Compsn。用于治疗周围循环系统疾病-包含前列腺素= E-1或其衍生物。且非内用:动脉

摘要

Compsns. for treating peripheral vascular disorders in humans with inadequate circulation in the extremities, contain sufficient of a PGE1 cpd. (I) to alleviate pain when the patient is resting, or to start healing of ulcers. The compsns. are administered by other than the intra-arterial route. (I) may be a PGE1 sa a lower alkyl, esp. methyl, ester or the amide and can be formulated as a saline or aq. soln. or as a coated tablet. The dangers and difficulties of intra-arterial injection are avoided, and (I) does not have to be passed through the lungs (where it undergoes rapid metabolism to relatively inactive cpds.,) before reaching the affected links. The relief of pain often lasts for several weeks after the end of the treatment.
机译:Compsns。用于治疗四肢循环不足的人的外周血管疾病时,应包含足够的PGE1 cpd。 (I)减轻患者休息时的疼痛或开始溃疡愈合。 compsns。通过动脉内途径以外的途径给药。 (I)可能是PGE1盐;低级烷基,特别是甲基,酯或酰胺,可以配制成盐水或水溶液soln。或作为包衣片剂。避免了动脉内注射的危险和困难,并且(I)在到达受影响的环节之前不必经过肺部(在该处肺部迅速代谢为相对无活性的cpds)。疼痛缓解通常在治疗结束后持续数周。

著录项

  • 公开/公告号DE2736320A1

    专利类型

  • 公开/公告日1978-02-16

    原文格式PDF

  • 申请/专利权人 CARLSONLARS A.;

    申请/专利号DE19772736320

  • 发明设计人 A. CARLSONLARS;

    申请日1977-08-12

  • 分类号A61K31/20;

  • 国家 DE

  • 入库时间 2022-08-22 21:56:01

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号